Description
The information represented in this report is a comprehensive analysis of the eye care
market globally with a special focus on the United States and selected international sectors.
The year ending December 31, 2008 was used as the base year with forecasts to the year
2013. Market statistics are given in U.S. dollars and in units [where appropriate]. Basis for
the market analysis consists of key data, statistics; references, and information from a large
data base of primary and secondary research sources documented in the report consisting of
interviews, professional meetings; conferences; presentations; journals; consumer media
[radio, TV, magazines, newspapers]; and Internet content involving more than 40,000
sources. Data were collected for global populations and medical providers who represent the
key influences in the eye care market.
The market analysis is comprised of two major sectors:
- refractive vision correction
[addressing myopia, hyperopia, presbyopia, and astigmatism]
- and major eye diseases
[addressing cataracts, glaucoma, AMD, retinal disorders].
Within the primary sectors the
analysis includes the top RVC treatment modalities [traditional and advanced laser systems;
RVC lens implants, and alternative surgical implants] and surgical intervention for each of
the major diseases [retinal laser surgery, photo dynamic therapy, pneumatic thermoplasticy,
capsulectomy, and trabeculectomy]. Competitive market shares are given for the key
manufacturers of RVC treatment methodologies and for major devices and ophthalmic
therapeutics employed in the management of eye diseases.
New technologies and treatment modalities for both visual acuity and major eye diseases may dramatically change the composition and competitive dynamics of the ophthalmology market. This report explores these dynamics and discoveries along with their profound impact on clinical eye care and the competitive positions of the market supplier. Also examined are traditional [conventional] approaches, the role of medical skills and techniques developed and cultivated over past years, and the importance of supporting increasingly global demand to correct vision deficiencies.
Other competitive technologies presented herein under the heading of refractive vision correction [RVC] include:
- Integrated [diagnostic] laser surgery
- RF conductive keratoplasty
- Earlier versions of corrective laser systems.
This segment also includes RVC breakthrough technologies such as
- Imaging topography
- Accommodating implants
- Special vision lens
- Vision restoration systems and
- Other evolving technologies
Vision abnormalities [restoration of impaired vision] presented and investigated are confined to following four primary conditions:
- Myopia [nearsightedness]—leading eye disorder affecting all age groups
- Hyperopia [farsightedness]—second leading eye disorder affecting all age groups
- Presbyopia [near focus abnormality]—phenomenon of aging, mostly 40 year olds
- Astigmatism [cornea irregularities, eye globe distortion]—affects all age groups
The range of therapeutic modalities mentioned above offers multiple options in treating one or more of the four primary diseases. While some modalities like ophthalmic pharmaceuticals are used to treat one disease, other medical devices like lasers and implants [Refocus Group’s PresView SRP—Scleral Lens Spacers] are more flexible and used in multiple applications for disease-specific procedures.
The market described herein is also positioning itself to resolve its most compelling
problems effecting older populations—the alarming increase in loss of vision worldwide
resulting from diseases, aging, and declining health conditions. The race is underway to
develop and exploit cutting-edge technologies [diagnostics, imaging, therapeutics, devices]
that will address the growing threat of deteriorating vision and blindness caused by the most
serious eye diseases, including:
- Cataracts—surgery & replacement intra ocular lens [IOL] and accommodating
lens,
- Glaucoma/Ocular Hypertension—chronic opened-angle and acute closedangle
• Age-Related Macular Degeneration [AMD]—both wet and dry, and
- Retinal Disorders—diabetic retinopathy, diabetic edema, detached retina.
While technological innovations continue to play a crucial role in slowing [or stopping]
the progress of vision loss through laser surgery and other medical and therapeutic
intervention, early diagnosis of these diseases and knowledge of available treatment options
is equally crucial to prevent the progression and further deterioration of vision. However, the
availability of technologies, medical disciplines, and skills to take advantage of the gains
made in managing eye diseases has yet to realize its full competitive and market potential. And many players entering this field will find this report a useful resource.
Table of Contents
TABLE OF CONTENTS
CHAPTER ONE: EXECUTIVE SUMMARY
- Overview
- Objectives, Scope, and Methodology
- Summary Of Findings
- Overview of Current Market Dynamics
- Market Analysis and Forecasts
CHAPTER TWO: INTRODUCTION AND OVERVIEW
- Overview
- History in Treating Eye Diseases
- World Demographics
- Population by Gender
- Aging Population
- Staggering World Facts
CHAPTER THREE: ISSUES AND TRENDS IN THE OPHTHALMOLOGY INDUSTRY
- Overview
- Resistance to Change
- The New Technological Revolution
- Refractive Vision Correction [RVC]
- Patient Reported Outcomes for Laser in situ Keratomileusis (LASIK) Surgery
- World Economy and Refractive Surgery
- Typical Refractive Demographic 2009
- Major Eye Diseases
- Regulation
- Government’s Role as Overseer
- Government Mandate: Safety & Effectiveness
- Developed & Underdeveloped Countries Off-Label Use Ophthalmologists vs Optometrists Business Challenges in a Regulated Environment
- Intellectual Property, Asset Ownership
- International Trade [Export/Import] Governance in a Publicly-Owned Company
CHAPTER FOUR: RESTORATION OF IMPAIRED VISION
- Treatment of Leading Vision Disorders
- The Global Opportunity
- Conventional Eye Glasses and Contact Lens
- Conventional Eye Glasses
- Traditional Contact Lenses
- Other Corrective Modalities
- LASIK/Laser Surgery Intervention
- RF Conductive Keratoplasty [RFK]
- Correctable Vision Implants—Spacers/Inserts
- Other Investigational Treatments for Presbyopia
- Temporary Correctable Vision Lenses
- Lens Implants—Phakic & Implantable Lens Implants [ICL]
- Challenges & Threats in the Global Marketplace
CHAPTER FIVE: DISEASES AFFECTING THE EYE
- Overview
- Cataracts
- Glaucoma
- Macular Degeneration
- Vitreoretinal Disorders
- Diabetic Retinopathy [DR]
- Diabetic Macular Edema [DME]
- Retinal Detachment [RD]
CHAPTER SIX: REFRACTIVE VISION CORRECTION: PRODUCTS AND TECHNOLOGIES
- Overview
- Competing Treatment Technologies
- Competitive Products, Technology, Applications & Market Status
CHAPTER SEVEN: MAJOR EYE DISEASES: PRODUCTS AND TECHNOLOGIES
- Overview
- Summary of Competing Technologies
- Cataract
- Glaucoma
- Age-Related Macular Degeneration
- Vitreoretinal Conditions
CHAPTER EIGHT: MARKET SUMMARY
- Description of the Market
- Eye Care Challenges
- The Aging Process and Complications of Chronic Conditions
- Technology Overcomes Obsolete Methodologies
- Older Treatment Modalities
- Advanced Treatment Modalities
- Pressures Influencing Structural Changes
- Market Influences
CHAPTER NINE: REFRACTIVE VISION CORRECTION MARKET ANALYSIS & FORECAST
- Background
- Eye Glasses & Contact Lenses
- Prevention & Wellness
- Laser Surgery & Other Corrective Alternatives
- Market and Competitive Analysis
Refractive Vision Correction Markets: Equipment, Supplies, and Devices
Refractive Vision Correction Markets: Services
CHAPTER TEN: MAJOR EYE DISEASES: MARKET ANALYSIS & FORECAST
- Market Challenges
- Market and Competitive Analysis
- Eye Disease Markets: Equipment, Supplies, and Devices
- Markets by Eye Disease
- Cataracts—Surgical Intervention and Devices
- Glaucoma Treatment and Management
- Vitreoretinal—Conventional & Advanced Treatments
- Other Treatments—Allergy, Dry Eye, Infection, Inflammation
- Eye Disease Markets: Services
CHAPTER ELEVEN:COMPANY PROFILES
- Overview
- Abbott Medical Optics, Inc
- Products/Technology/Intellectual Property
- Financial Performance and Segment Analysis
- Alcon, Inc
- Products/Technology/Intellectual Property
- Focus & Future Strategy
- Allergan, Inc
- Business Overview
- Products and Strategy
- Heidelberg Engineering, Inc
- Business Overview
- Products and Technology
- Nidek Co. Ltd.
- Business Overview
- Products/Technology/Intellectual Property
- STAAR Surgical Company
- Business Overview
- Products/Technology/Intellectual Property
- Strategy
- Novartis
- Business Overview
- Products & Strategy
- Carl Zeiss Meditec AG
- Products, Strategy and Focus
APPENDIX A: GLOSSARY AND ABBREVIATIONS
APPENDIX B: PROFESSIONAL/SCIENTIFIC SOURCES
APPENDIX C: NEWS/RESEARCH SOURCES
APPENDIX D: U.S. REGULATORY AUTHORITIES AND STATUTES
APPENDIX E: INTERNATIONAL REGULATORY AUTHORITIES AND STATUTES
APPENDIX F: ASSOCIATIONS, SOCIETIES, FOUNDATIONS FOR EYE HEALTH
LIST OF EXHIBITS
CHAPTER ONE: EXECUTIVE SUMMARY
- Table 1-1: Ophthalmology Market: Product and Service Revenues [combined eye diseases and refractive], 2006-2013
CHAPTER TWO: INTRODUCTION AND OVERVIEW
- Table 2-1: Estimated and Projected World Population by Selected Geographical Region, 2008-2050 (in millions)
- Figure 2-1: Estimated and Projected World Population by Selected Geographical Region, 2008-2050
- Table 2-2: Number and Percent Population by Sex and Region, 2008
- Table 2-3: Estimated World Population by Age and Geographical Region, 2008 (in millions)
- Figure 2-2: Estimated World Population by Age and Geographical Region, 2008
- Figure 2-3: Estimated World Population by Age Group
CHAPTER FOUR: RESTORATION OF IMPAIRED VISION
- Table 4-1: Primary Visual Acuity Conditions and Refractive Vision Correction Treatment Options
CHAPTER FIVE: DISEASES AFFECTING THE EYE
- Table 5-1: Diagnostics & Treatment Modalities for the Management of Eye Diseases
CHAPTER SIX: REFRACTIVE VISION CORRECTION: PRODUCTS AND TECHNOLOGIES
- Table 6-1: Refractive Vision Correction Competitive Products, Technology, Application, Market Status
CHAPTER SEVEN: MAJOR EYE DISEASES: PRODUCTS AND TECHNOLOGIES
- Table 7-1: Major Eye Diseases Competitors, Competitive Products, Technology, Application, and Market Status
CHAPTER EIGHT: MARKET SUMMARY
- Table 8-1: Ophthalmology Market: Product and Service Revenues [combined eye diseases and refractive], 2006-2013
CHAPTER NINE: REFRACTIVE VISION CORRECTION MARKET ANALYSIS & FORECAST
- Table 9-1: Refractive Vision Correction Market: Equipment and Product Revenues and Annual Growth by Geography (U.S. and Non-U.S.), 2006-2013
- Table 9-2: Refractive Vision Correction Market: Equipment and Product Supplier Revenues and Market Share by Geography, 2008
- Table 9-3: Refractive Vision Correction Market: Service Revenues and Annual Growth by Geography (U.S. and Non-U.S.), 2006-2013
- Table 9-4: Refractive Vision Correction Market: Service Revenues and Market Share by Provider Type and Geography, 2008
- Table 9-5: Refractive Vision Correction Market: Service Revenues and Market Share by Geography (U.S. vs Non-U.S.) and Condition Treated (Myopia, Hyperopia, Presbyopia, Astigmatism), 2008
CHAPTER TEN: MAJOR EYE DISEASES: MARKET ANALYSIS & FORECAST
- Table 10-1: Eye Disease Market: Product Revenues and Annual Growth by Geography (U.S. and Non-U.S.), 2006-2013
- Table 10-2: Eye Disease Market: Supplier Revenues and Market Share by Geography, 2008
- Table 10-3: Major Eye Disease Market: Supplier Revenues and Market Share by Condition (Cataract, Glaucoma, Vitreoretinal, Others), 2008
- Table 10-4: Eye Disease Treatment Market: Service Revenues and Annual Growth by Geography (U.S. and Non-U.S.), 2006-2013
- Table 10-5: Eye Disease Treatment Market: Service Revenues and Market Share by Provider Type and Geography, 2008
- Table 10-6: Eye Disease Treatment Market: Provider Service Revenues and Market Share by Geography (U.S. vs Non-U.S.) and Condition Treated (Cataract, Glaucoma, Vitreoretinal, Other), 2008
